We are live on
!
Find out more
SFM
Sphera Funds Management Portfolio holdings
AUM
$630M
1-Year Est. Return
108.65%
This Fund
S&P 500
This Quarter
Est. Return
+9.45%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$359M
AUM Growth
–
Cap. Flow
+$346M
Cap. Flow
% of AUM
96.43%
Top 10 Holdings %
Top 10 Hldgs %
47.3%
Holding
96
New
96
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$28.5M |
| 2 |
Pfizer
PFE
|
+$21.5M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$16M |
| 4 |
Merck
MRK
|
+$13.4M |
| 5 |
SHPG
Shire pic
SHPG
|
+$8.54M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.19% |
| 2 | Consumer Discretionary | 4.33% |
| 3 | Technology | 3.68% |
| 4 | Industrials | 3.52% |
| 5 | Consumer Staples | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
51
DELISTED
MEDIVATION, INC.
MDVN
| $1.92M | 0.53% |
+60,000
| New | +$1.81M |
|
|
YHOO
52
DELISTED
Yahoo Inc
YHOO
| $1.78M | 0.5% |
+44,138
| New | +$1.58M |
|
53
Silicom
SILC
$229M
| $1.73M | 0.48% |
+37,821
| New | +$1.59M |
|
|
KBIO
54
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $1.7M | 0.47% |
+48,125
| New | +$1.61M |
|
|
MDCO
55
DELISTED
Medicines Co
MDCO
| $1.7M | 0.47% |
+44,000
| New | +$1.57M |
|
|
TLOG
56
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $1.67M | 0.46% |
+175,000
| New | +$1.37M |
|
|
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.63M | 0.46% |
+63,471
| New | +$1.54M |
|
58
Sarepta Therapeutics
SRPT
$1.57B
| $1.63M | 0.45% |
+80,000
| New | +$2.38M |
|
59
Acadia Pharmaceuticals
ACAD
$4.43B
| $1.5M | 0.42% |
+60,000
| New | +$1.42M |
|
|
INFI
60
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.38M | 0.38% |
+100,000
| New | +$1.41M |
|
61
Traws Pharma
TRAW
$6.85M
| $1.38M | 0.38% |
+2
| New | +$1.89M |
|
62
Xencor
XNCR
$1.5B
| $1.35M | 0.38% |
+148,000
| New | +$1.27M |
|
63
Prothena Corp
PRTA
$425M
| $1.33M | 0.37% |
+50,000
| New | +$1.25M |
|
|
CASC
64
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.32M | 0.37% |
+124,723
| New | +$1.39M |
|
65
Chipotle Mexican Grill
CMG
$47.2B
| $1.3M | 0.36% |
+122,500
| New | +$1.25M |
|
66
PTC Therapeutics
PTCT
$5.64B
| $1.25M | 0.35% |
+73,583
| New | +$1.29M |
|
67
Gyre Therapeutics
GYRE
$641M
| $1.25M | 0.35% |
+381
| New | +$1.5M |
|
68
Radware
RDWR
$1.1B
| $1.21M | 0.34% |
+67,268
| New | +$1.06M |
|
69
Ionis Pharmaceuticals
IONS
$8.6B
| $1.2M | 0.33% |
+30,000
| New | +$1.07M |
|
70
Nike
NKE
$61.9B
| $1.18M | 0.33% |
+29,988
| New | +$1.15M |
|
71
Vanda Pharmaceuticals
VNDA
$307M
| $1.18M | 0.33% |
+95,000
| New | +$954K |
|
|
WINT
72
DELISTED
Windtree Therapeutics Inc
WINT
| $1.13M | 0.31% |
+35,714
| New | +$1.12M |
|
|
QLTI
73
DELISTED
QLT Inc
QLTI
| $1.11M | 0.31% |
+200,000
| New | +$991K |
|
74
Cytokinetics
CYTK
$10.5B
| $1.09M | 0.3% |
+167,000
| New | +$1.1M |
|
|
XOMA
75
DELISTED
Xoma
XOMA
| $1.08M | 0.3% |
+8,000
| New | +$806K |
|
Similar funds
VIM
KCMH
FCFC
BI
PWW
TTSTC
SWP
EIM
Sphera Funds Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Sphera Funds Management, which disclosed 96 positions worth $359M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is GSK: 440,000 shares worth $29.4M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Consumer Discretionary and Technology.
- Sphera Funds Management's largest Q4 2013 buy was GSK: 440,000 shares worth $29.4M.
- Sphera Funds Management's ten largest holdings make up 47% of its $359M portfolio in Q4 2013.
- Sphera Funds Management disclosed 96 positions in Q4 2013, its first 13F filing on record.
Based on Sphera Funds Management's 13F filing for Q4 2013, filed 13 Feb 2014.